Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide with Peptide Vaccines in Melanoma
NCT00254397Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2005
- Primary completion
- Oct 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in melanoma, Uveal melanoma (UM), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2005; status: completed.
02
Drugs
leuprolide
03
Conditions
melanomaUveal melanoma (UM)
Beyond the preview
Go deeper on NCT00254397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254397.